WMSA
ADPT icon

Weiss Multi-Strategy Advisers’s Adaptive Biotechnologies ADPT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,000
Closed -$632K – 671
2020
Q3 		$632K Sell
13,000
-1,000
-7% -$42K 0.02% 459
2020
Q2 		$677K Sell
14,000
-535
-4% -$19.5K 0.02% 449
2020
Q1 		$404K Buy
+14,535
New +$405K 0.02% 356

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ADPT Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of Adaptive Biotechnologies (ADPT) in Q4 2020, closing a stake of 13,000 shares — an estimated $632K sold.

Weiss Multi-Strategy Advisers first reported a position in ADPT in Q1 2020 and held it in 3 quarters. The position peaked at $677K in Q2 2020. 250 funds tracked by Wall St. Rank hold ADPT as of Q4 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Adaptive Biotechnologies position as of Q4 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 13,000 Adaptive Biotechnologies shares in Q4 2020, an estimated $632K.
  • Weiss Multi-Strategy Advisers first reported a position in Adaptive Biotechnologies in Q1 2020 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's Adaptive Biotechnologies position peaked at $677K in Q2 2020.
  • 250 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.